Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single Use Equipment, Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Biopharma, CMOs), Region - Global Forecast to 2027

Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Cell Culture Vessels, Single Use Equipment, Systems & Software), Process (Cell Processing), Cell Type (T-cells, Stem Cells), End User (Biopharma, CMOs), Region - Global Forecast to 2027

The cell therapy technologies market is projected to reach USD 8.0 Billion by 2027 from USD 4.0 Billion in 2022, at a CAGR of 14.6% during the forecast period. The growth can be attributed to the increasing public-private partnerships. Several government and private organizations have made significant investments to strengthen R&D in cell therapy leading to surge in cell therapy technologies demand, hence propelling market growth.

“The cell preservation and distribution and handling process segment accounted for the second largest share of the market in 2021”

Cell preservation and distribution is an essential and vital step in the cell scaling-up process. In addition, with the growth in the demand for cell-based medical products and therapies, the demand for reliable storage equipment to preserve finite cell lines and cells manufactured in excess is expected to increase. This factor is expected to drive the growth of this market segment.

“The CROs and CMOs accounted for the second largest share of the cell therapy technologies market in 2021”

To cater the large demand, pharmaceutical companies need to speed up clinical timelines, maintain business continuity, and free up resources for projects. This has increased outsourcing analytical tests to CROs and CMOs, thereby boosting the segment market growth.

Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza Group (Switzerland), Sartorius AG (Germany), Terumo BCT (US), Becton, Dickinson and Company (US), Fresenius SE & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US), Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte Inc. (US), Werum IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH (Germany), TrakCel (UK), L7 Informatics, Inc. (US), Miltenyi Biotec GmbH (Germany), STEMCELL Technologies (Canada), GPI Iberia (Spain), MAK-SYSTEM (US), OrganaBio, LLC (US), IxCells Biotechnology (China), and Wilson Wolf Manufacturing Corporation (US), are some of the major players operating in the market.

“Asia Pacific: The fastest-growing region in the cell therapy technologies market”

The Asia Pacific market is expected to register the highest CAGR during the forecast period. Some of the major factors contributing to the growth of the Asia Pacific market are low-cost manufacturing advantage, increasing per capita income, and growing need to curb cancer. In addition, the growth of geriatric population is also fueling the cell therapy technologies market in the region.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 80% and Demand Side - 20%

By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%

By Region: North America -20%, Europe -10%, Asia-Pacific -55%, RoW -15%

List of Companies Profiled in the Report:

Thermo Fisher Scientific, Inc. (US)

Merck KGaA (Germany)

Danaher Corporation (US)

Lonza Group (Switzerland)

Sartorius AG (Germany)

Terumo BCT (US)

Becton, Dickinson and Company (US)

Fresenius SE & Co. KGaA (Germany)

Avantor, Inc. (US)

Bio-Techne Corporation (US)

Corning Incorporated (US)

FUJIFILM Irvine Scientific (US)

MaxCyte Inc. (US)

Werum IT Solutions GmbH (Germany)

RoosterBio Inc. (US)

SIRION Biotech GmbH (Germany)

TrakCel (UK)

L7 Informatics, Inc. (US)

Miltenyi Biotec GmbH (Germany)

STEMCELL Technologies (Canada)

GPI Iberia (Spain)

MAK-SYSTEM (US), OrganaBio, LLC (US)

IxCells Biotechnology (China)

Wilson Wolf Manufacturing Corporation (US)

Research Coverage:

This report provides a detailed picture of the cell therapy technologies market. It aims at estimating the size and future growth potential of the market across different segments such as the product, process, cell type, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall cell therapy technologies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, trends, and opportunities.